NME1 antibody
Quick Overview for NME1 antibody (ABIN5704006)
Target
See all NME1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Immunogen
- non-metastatic cells 1, protein (NM23A) expressed in
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
HeLa cells were subjected to SDS PAGE followed by western blot with FNab05762(NME1 antibody) at dilution of 1:1500
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze / thaw cycles.
-
Storage
- -20 °C
-
Expiry Date
- 12 months
-
-
- NME1 (Non-Metastatic Cells 1, Protein (NM23A) Expressed in (NME1))
-
Alternative Name
- NME1
-
Background
- Synonyms:NDPKA, NM23 Background:This gene (NME1) was identified because of its reduced mRNA transcript levels in highly metastatic cells. Nucleoside diphosphate kinase (NDK) exists as a hexamer composed of 'A' (encoded by this gene) and 'B' (encoded by NME2) isoforms. Mutations in this gene have been identified in aggressive neuroblastomas. Two transcript variants encoding different isoforms have been found for this gene. Co-transcription of this gene and the neighboring downstream gene (NME2) generates naturally-occurring transcripts (NME1-NME2), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product.
-
Molecular Weight
- 16-20 kDa
-
Gene ID
- 4830
-
UniProt
- P15531
-
Pathways
- Apoptosis, Nucleotide Phosphorylation, Carbohydrate Homeostasis, Ribonucleoside Biosynthetic Process
Target
-